Skip Navigation

European Journal of Heart Failure 2000 2(2):145-150; doi:10.1016/S1388-9842(00)00067-2
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (13)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Sharma, J. C.
Right arrow Articles by Ross, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sharma, J. C.
Right arrow Articles by Ross, I.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2000 European Society of Cardiology

Cardiovascular disease and outcome of acute stroke: influence of pre-existing cardiac failure

Jagdish C. Sharmaa,*, Sally Fletchera, Michael Vassalloa and Ian Rossb

a King's Mill Centre for Healthcare Services Mansfield Road, Sutton in Ashfield, Nottinghamshire NG18, UK
b Newark Hospital Newark NG24 4DE, UK

* Corresponding author. Mansfield Community Hospital, Stockwell Gate, Mansfield NG18 5QJ, UK. Tel.: +44-1623-785-045; fax: +44-1623-785-180. E-mail address: jsharma{at}lineone.net (J.C. Sharma).


   Abstract

Background and aims: Whilst a number of variables, mostly a consequence of a stroke, are known to predict mortality of acute stroke there is limited information on the significance of pre-existing cardiovascular variables on stroke mortality. We have investigated the influence of pre-existing cardiovascular factors in one cohort of stroke patients.

Methods: We studied 295 patients, mean age 74 ± 10 (range 34–96) years; 133 males, presenting with acute stroke for pre-existing cardiovascular disease (CVD) defined as hypertension, atrial fibrillation (AF), ischaemic heart disease (IHD) and cardiac failure (CF). In addition, data were collected on epidemiological and neurological variables known to influence stroke mortality. The most significant of the cardiovascular factors was further investigated against all the other cardiovascular groups together and against those without any CVD. Outcome was measured as their influence on acute phase and 3-month mortality.

Results: There was no significant difference in 3-month mortality with hypertension (P = 0.62) and IHD (P = 0.33) but there was a significant higher mortality in patients with AF (P = 0.05) and CF (P < 0.001). CF was more significant than all other CVD (hypertension+AF+IHD) together without the failure (P < 0.001); odds ratio of 4.5 (95% CI 2.28–9.07). Partial correlation coefficient revealed CF to be an independent significant variable to influence stroke mortality when controlled with AF, stroke syndromes, age, incontinence, pyrexia, dysphagia and Glasgow coma score.

Conclusions: Pre-existing CF has an adverse influence on stroke mortality independent of other known factors. Cardiovascular factors without failure do not have such an effect except the marginal effect of AF.

Key Words: Stroke mortality • Cardiac failure • Cardiovascular factors

Received February 18, 2000; Accepted February 22, 2000


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Am Board Fam MedHome page
R. P. Blankfield
Can Natriuretic Peptide Levels Predict the Cardiovascular Complications of COX-2 Inhibitors and Nonsteroidal Anti-inflammatory Drugs?
J Am Board Fam Med, March 1, 2006; 19(2): 178 - 182.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C. Steger, A. Pratter, M. Martinek-Bregel, M. Avanzini, A. Valentin, J. Slany, and C. Stollberger
Stroke patients with atrial fibrillation have a worse prognosis than patients without: data from the Austrian Stroke registry
Eur. Heart J., October 1, 2004; 25(19): 1734 - 1740.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. C. Sharma, P. Appelros, I. Nydevik, and M. Viitanen
Poor Outcome After First-Ever Stroke * Response
Stroke, August 1, 2003; 34 (8): e104 - e104.
[Full Text] [PDF]


Home page
StrokeHome page
J. C. Sharma, A. Di Carlo, M. Lamassa, and D. Inzitari
Re: Characteristics, Outcome, and Care of Stroke Associated With Atrial Fibrillation in Europe
Stroke, September 1, 2001; 32(9): 2206 - 2206.
[Full Text] [PDF]


Home page
NeurologyHome page
H. Hassaballa, P. B. Gorelick, C. P. West, M. D. Hansen, and H. P. Adams Jr.
Ischemic stroke outcome: Racial differences in the trial of danaparoid in acute stroke (TOAST)
Neurology, August 28, 2001; 57(4): 691 - 697.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.